{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:14:18Z","timestamp":1792728858352,"version":"4.5.0"},"reference-count":34,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>von Willebrand factor (VWF) is a promising target for developing antithrombotic drugs. The absence of accessible animal models impedes the study of specific human VWF (huVWF) targeting molecules in thrombosis. huVWF is not functional in the mouse because of a lack of interaction between huVWF and murine glycoprotein Ib. Using site-directed mutagenesis, we have replaced single or multiple amino acids in huVWF with their murine counterparts to eliminate species incompatibility. Using hydrodynamic injection, we have expressed the different chimeric VWF constructs into VWF\u2212\/\u2212 mice. Only huVWF with a complete murine A1 domain insertion was able to correct bleeding in vivo and form occlusive thrombi in mesenteric vessels after FeCl3 treatment. Using this model, we tested the antithrombotic effect of monoclonal antibodies against huVWF, blocking its interaction with collagens (mAbs 203 and 505) or with glycoprotein IIbIIIa (mAb 9). The 3 mAbs inhibited the thrombotic process in arterioles of VWF\u2212\/\u2212 mice expressing huVWFmuA1. Inhibiting VWF-interaction with collagens was more potent, emphasizing the potential of such a target as an antithrombotic tool. Our results validate our murine model as a simple in vivo tool to evaluate anti-huVWF agents.<\/jats:p>","DOI":"10.1182\/blood-2012-03-420042","type":"journal-article","created":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T00:51:11Z","timestamp":1345510271000},"page":"2723-2732","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":22,"title":["A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor"],"prefix":"10.1182","volume":"120","author":[{"given":"Ana-Maria","family":"Navarrete","sequence":"first","affiliation":[{"name":"Inserm U770, Le Kremlin-Bic\u00eatre, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Casari","sequence":"additional","affiliation":[{"name":"Inserm U770, Le Kremlin-Bic\u00eatre, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"Legendre","sequence":"additional","affiliation":[{"name":"Inserm U770, Le Kremlin-Bic\u00eatre, France; and"},{"name":"Unite Mixte de Recherche S770, Universit\u00e9 Paris Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Marx","sequence":"additional","affiliation":[{"name":"Inserm U770, Le Kremlin-Bic\u00eatre, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun-Ruey","family":"Hu","sequence":"additional","affiliation":[{"name":"Inserm U770, Le Kremlin-Bic\u00eatre, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Lenting","sequence":"additional","affiliation":[{"name":"Inserm U770, Le Kremlin-Bic\u00eatre, France; and"},{"name":"Unite Mixte de Recherche S770, Universit\u00e9 Paris Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier D.","family":"Christophe","sequence":"additional","affiliation":[{"name":"Inserm U770, Le Kremlin-Bic\u00eatre, France; and"},{"name":"Unite Mixte de Recherche S770, Universit\u00e9 Paris Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile V.","family":"Denis","sequence":"additional","affiliation":[{"name":"Inserm U770, Le Kremlin-Bic\u00eatre, France; and"},{"name":"Unite Mixte de Recherche S770, Universit\u00e9 Paris Sud, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2019111812190367300_B1","first-page":"e46","article-title":"Heart disease and stroke statistics-2010 update: a report from the American Heart Association.","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"issue":"24","key":"2019111812190367300_B2","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis.","volume":"357","author":"Davi","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111812190367300_B3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes (1).","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111812190367300_B4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrd985","article-title":"Scientific and therapeutic advances in antiplatelet therapy.","volume":"2","author":"Bhatt","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2019111812190367300_B5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00062752-200303000-00008","article-title":"Von Willebrand factor.","volume":"10","author":"Ruggeri","year":"2003","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"2019111812190367300_B6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","article-title":"Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.","volume":"84","author":"Savage","year":"1996","journal-title":"Cell"},{"issue":"26","key":"2019111812190367300_B7","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.2174\/138161207781662867","article-title":"Inhibition of platelet glycoprotein Ib and its antithrombotic potential.","volume":"13","author":"Vanhoorelbeke","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"3","key":"2019111812190367300_B8","first-page":"539","article-title":"A dose ranging phase I\/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura.","volume":"106","author":"Jilma-Stohlawetz","year":"2011","journal-title":"Thromb Haemost"},{"issue":"8","key":"2019111812190367300_B9","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/STROKEAHA.111.616649","article-title":"The von Willebrand inhibitor ARC1779 reduces cerebral embolization after carotid endarterectomy: a randomized trial.","volume":"42","author":"Markus","year":"2011","journal-title":"Stroke"},{"issue":"10","key":"2019111812190367300_B10","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V99.10.3623","article-title":"Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons.","volume":"99","author":"Wu","year":"2002","journal-title":"Blood"},{"issue":"12","key":"2019111812190367300_B11","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1586\/erc.10.154","article-title":"Targeting von Willebrand factor and platelet glycoprotein Ib receptor.","volume":"8","author":"Firbas","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"2019111812190367300_B12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1182\/blood.V77.3.519.519","article-title":"Role of von Willebrand factor associated to extracellular matrices in platelet adhesion.","volume":"77","author":"Baruch","year":"1991","journal-title":"Blood"},{"issue":"1","key":"2019111812190367300_B13","first-page":"58","article-title":"von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein Ib.","volume":"112","author":"Fressinaud","year":"1988","journal-title":"J Lab Clin Med"},{"issue":"5","key":"2019111812190367300_B14","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1182\/blood.V67.5.1356.1356","article-title":"Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb\/IIIa and with collagen using monoclonal antibodies.","volume":"67","author":"Girma","year":"1986","journal-title":"Blood"},{"issue":"3","key":"2019111812190367300_B15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1182\/blood-2008-02-142943","article-title":"Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa.","volume":"112","author":"Marx","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111812190367300_B16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/ATVBAHA.107.159442","article-title":"Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutants.","volume":"28","author":"Marx","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"2019111812190367300_B17","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/j.1538-7836.2005.01571.x","article-title":"Cysteine-mutations in von Willebrand factor associated with increased clearance.","volume":"3","author":"Van Schooten","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111812190367300_B18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-1119(89)90358-2","article-title":"Site-directed mutagenesis by overlap extension using the polymerase chain reaction.","volume":"77","author":"Ho","year":"1989","journal-title":"Gene"},{"issue":"1","key":"2019111812190367300_B19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-1119(89)90359-4","article-title":"Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.","volume":"77","author":"Horton","year":"1989","journal-title":"Gene"},{"issue":"16","key":"2019111812190367300_B20","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis.","volume":"95","author":"Denis","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2019111812190367300_B21","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M310436200","article-title":"An experimental model to study the in vivo survival of von Willebrand factor: basic aspects and application to the R1205H mutation.","volume":"279","author":"Lenting","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"2019111812190367300_B22","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1055\/s-0037-1614779","article-title":"Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF.","volume":"82","author":"Obert","year":"1999","journal-title":"Thromb Haemost"},{"issue":"44","key":"2019111812190367300_B23","doi-asserted-by":"crossref","first-page":"31990","DOI":"10.1074\/jbc.M701596200","article-title":"Involvement of the mitogen-activated protein kinase c-Jun NH2-terminal kinase 1 in thrombus formation.","volume":"282","author":"Kauskot","year":"2007","journal-title":"J Biol Chem"},{"issue":"2","key":"2019111812190367300_B24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-0038-1647310","article-title":"Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.","volume":"64","author":"Girma","year":"1990","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111812190367300_B25","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1055\/s-0038-1642524","article-title":"Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.","volume":"71","author":"Pietu","year":"1994","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019111812190367300_B26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0037-1614642","article-title":"New assay for measuring binding of platelet glycoprotein IIb\/IIIa to unpurified von Willebrand factor.","volume":"82","author":"Veyradier","year":"1999","journal-title":"Thromb Haemost"},{"issue":"23","key":"2019111812190367300_B27","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1182\/blood-2009-11-254193","article-title":"Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.","volume":"115","author":"Rayes","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111812190367300_B28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nbt1373","article-title":"Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies.","volume":"26","author":"Chen","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"5584","key":"2019111812190367300_B29","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1126\/science.107355","article-title":"Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.","volume":"297","author":"Huizinga","year":"2002","journal-title":"Science"},{"issue":"6","key":"2019111812190367300_B30","first-page":"1343","article-title":"Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor-collagen interaction in baboons.","volume":"98","author":"De Meyer","year":"2007","journal-title":"Thromb Haemost"},{"issue":"25","key":"2019111812190367300_B31","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1182\/blood-2011-09-380535","article-title":"A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13.","volume":"119","author":"Schiviz","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2019111812190367300_B32","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.V93.6.1959.406k01_1959_1968","article-title":"Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.","volume":"93","author":"Obert","year":"1999","journal-title":"Blood"},{"issue":"2","key":"2019111812190367300_B33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1568006033481500","article-title":"Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs.","volume":"3","author":"Vanhoorelbeke","year":"2003","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"issue":"2","key":"2019111812190367300_B34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/hq0202.102321","article-title":"Inhibition of platelet glycoprotein Ib, glycoprotein IIb\/IIIa, or both by monoclonal antibodies prevents arterial thrombosis in baboons.","volume":"22","author":"Wu","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/13\/2723\/1358957\/zh803912002723.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/13\/2723\/1358957\/zh803912002723.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T15:01:09Z","timestamp":1594566069000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/13\/2723\/30843\/A-murine-model-to-characterize-the-antithrombotic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,27]]},"references-count":34,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,9,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-03-420042","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,27]]}}}